Abstract
Ellagic acid is a polyphenol antioxidant found in numerous fruits and vegetables including raspberries, strawberries, cranberries, walnuts, pecans, pomegranates and other plant foods. The antiproliferative and antioxidant properties of ellagic acid have spurred several researches into the potential health benefits of its consumption, leading to its marketing as a dietary supplement. Recently, ellagic acid was shown to display interesting and usable antimalarial activity. However, the relatively insolubility of this compound in water and organic solvents, and its low bioavailability tend to disqualify it as a potential drug candidate. In this review, we will discuss the potential of ellagic acid and derivatives as antimalarial drug candidates. While highlighting their numerous biological and pharmacological activities against other human ailments, we will evaluate the possibility of developing this family of compounds as antimalarial drugs, and discuss strategies and related challenges to achieve that goal.
Keywords: Ellagic acid and derivatives, synthesis, antimalarial activity, other biological and pharmacological properties
Current Bioactive Compounds
Title: The Potential of Ellagic Acid as a Possible Antimalarial Drug Candidate
Volume: 6 Issue: 3
Author(s): Jean Fotie
Affiliation:
Keywords: Ellagic acid and derivatives, synthesis, antimalarial activity, other biological and pharmacological properties
Abstract: Ellagic acid is a polyphenol antioxidant found in numerous fruits and vegetables including raspberries, strawberries, cranberries, walnuts, pecans, pomegranates and other plant foods. The antiproliferative and antioxidant properties of ellagic acid have spurred several researches into the potential health benefits of its consumption, leading to its marketing as a dietary supplement. Recently, ellagic acid was shown to display interesting and usable antimalarial activity. However, the relatively insolubility of this compound in water and organic solvents, and its low bioavailability tend to disqualify it as a potential drug candidate. In this review, we will discuss the potential of ellagic acid and derivatives as antimalarial drug candidates. While highlighting their numerous biological and pharmacological activities against other human ailments, we will evaluate the possibility of developing this family of compounds as antimalarial drugs, and discuss strategies and related challenges to achieve that goal.
Export Options
About this article
Cite this article as:
Fotie Jean, The Potential of Ellagic Acid as a Possible Antimalarial Drug Candidate, Current Bioactive Compounds 2010; 6 (3) . https://dx.doi.org/10.2174/157340710793237344
DOI https://dx.doi.org/10.2174/157340710793237344 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cytochromes P450 in the Bioactivation of Chemicals
Current Topics in Medicinal Chemistry NF-κB Blockers Gifted by Mother Nature: Prospectives in Cancer Cell Chemosensitization
Current Pharmaceutical Design Chemopreventive Properties of Peptide Lunasin: A Review
Protein & Peptide Letters May Patients with Alcohol Liver Disease Benefit from Herbal Medicines?
Reviews on Recent Clinical Trials Molecular Biological Roles of Ursolic Acid in the Treatment of Human Diseases
Current Bioactive Compounds Subject Index to Volume 3
Current Medicinal Chemistry - Central Nervous System Agents Teratogenic Toxicity Evaluation of Bladder Cancer-Specific Oncolytic Adenovirus on Mice
Current Gene Therapy Chemokine Receptors as Targets for Cancer Therapy
Current Pharmaceutical Design Carbonic Anhydrase IX as a Target for Designing Novel Anticancer Drugs
Current Medicinal Chemistry E-Cadherin Upregulation as a Therapeutic Goal in Cancer Treatment
Mini-Reviews in Medicinal Chemistry Oxygen Sensing, Cardiac Ischemia, HIF-1α and Some Emerging Concepts
Current Cardiology Reviews Recent Advances in the Synthesis and Anticancer Activity of Some Molecules Other Than Nitrogen Containing Heterocyclic Moeities
Mini-Reviews in Medicinal Chemistry Applications of Gene Therapy to the Treatment of Chronic Pain
Current Gene Therapy Flavaglines: Their Discovery from Plants Used in Traditional Chinese Medicine, Synthesis, and Drug Development Against Cancer and Immune Disorders
Current Chinese Chemistry Mechanisms of Drug Resistance to Vascular Endothelial Growth Factor (VEGF) Inhibitors
Anti-Cancer Agents in Medicinal Chemistry Patents on Immunotoxins and Chimeric Toxins for the Treatment of Cancer
Recent Patents on Drug Delivery & Formulation Molecular Recognition at Purine and Pyrimidine Nucleotide (P2) Receptors
Current Topics in Medicinal Chemistry Multimodality Imaging of CXCR4 in Cancer: Current Status towards Clinical Translation
Current Molecular Medicine A Review on Natural Sources Derived Protein Nanoparticles as Anticancer Agents
Current Topics in Medicinal Chemistry Patent Annotations
Recent Patents on Anti-Cancer Drug Discovery